felbamate has been researched along with evans blue in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Angileri, FF; Arcadi, F; Bramanti, P; Caffo, M; Caruso, G; Costa, C; Germanò, A; Hayes, RL; Lewis, SB; Meli, F; Newcomb-Fernandez, J; Pineda, JA; Wang, KK | 1 |
2 other study(ies) available for felbamate and evans blue
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat.
Topics: Animals; Behavior, Animal; Blood-Brain Barrier; Body Weight; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Evans Blue; Felbamate; Male; Microcirculation; Neuroprotective Agents; Phenylcarbamates; Postural Balance; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spectrometry, Fluorescence; Subarachnoid Hemorrhage | 2007 |